GLP-3 (R) 5 mg Certificate of Analysis
- Product
- GLP-3 (R) 5 mg
- Report number
- CPT-RETATR-A337C9
- Batch / lot
- L25-01 · CGX-2025
- Tested
- Sep 27, 2026
- Reported
- Oct 3, 2026
- Laboratory
- Canada Peptide Testing (independent)
- Method
- HPLC-UV purity and content
- Reported purity
- 99.96%
- Measured content
- 5.97 mg (expected 5.00 mg)
- Fill accuracy
- 119.4%
How to read this certificate
- Report number: the lab’s ID for this test. The QR code on the certificate and the Verify button open the same record on canadapeptidetesting.com.
- HPLC purity: the share of the main compound among everything the chromatography column detected in the sample.
- Content: the measured amount of compound in the vial, compared with the labelled amount.
- Tested date: when the lab ran the sample. Each lot is tied to its own report.
About GLP-3 (R)
A synthetic peptide designed to act at three receptors: GIP, GLP-1 and glucagon.
Testing history for this product
| Tested | Laboratory | Batch | Purity | Report |
|---|---|---|---|---|
| Sep 27, 2026 | Canada Peptide Testing | L25-01 | 99.96% | CPT-RETATR-A337C9 |
| Dec 8, 2025 | Testides | — | 99.97% | CEP-RETA-5-112625 |
Related certificates
Reported results apply to the tested lot. For research use only. Not for use in diagnostic or therapeutic procedures.
